Audited Results of Marksans Pharma Ltd. Company

(Rs in Cr.) Mar 31, 2026 Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Operating Income 1,341.48 1,174.37 853.27 655.20 658.29
Manufacturing Expenses 0 30.73 26.04 14.24 11.27
Personnel Expenses 121.98 101.68 77.19 56.09 60.46
Selling Expenses 0 0 0 0 0
Administrative Expenses 217.15 197.98 131.17 98.52 95.25
Expenses Capitalised 0 0 0 0 0
Cost Of Sales 1,017.91 970.32 713.34 563.30 544.57
Operating Profit 323.57 204.05 139.94 91.90 113.72
Other Recurring Income 103.53 69.83 62.07 60.48 42.25
Adjusted PBDIT 427.10 273.88 202.01 152.38 155.97
Financial Expenses 1.33 1.17 0.99 3.61 3.79
Depreciation 34.23 29.45 29.13 16.74 17.66
Other Write offs 0 0 0 0 0
Adjusted PBT 391.54 243.26 171.89 132.03 134.51
Tax Charges 90.84 54.99 38.13 29.17 30.52
Adjusted PAT 300.70 188.27 133.76 102.87 103.99
Non Recurring Items 0 -0.30 0.28 -0.59 0.05
Other Non Cash adjustments 0 0 0 0 0
Reported Net Profit 300.70 188.27 133.76 102.87 103.99
Equity Dividend 0 27.19 22.66 10.17 10.23
Preference Dividend 0 0 0 0 0
Retained Earnings 300.70 505.78 345 247.31 155.21

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+
X